Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Finasteride can cause sexual problems and depression in young men.

Childhood ptosis can vary from a minor cosmetic issue to a serious condition and may signal other health problems.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Nano selenium and CoQ10 helped reduce blood fat levels and insulin resistance while preventing muscle damage from statin drugs in rats.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

A woman developed facial hair cysts after using a 3% minoxidil solution for hair loss, which disappeared after stopping the treatment and removing the cysts surgically.

Kerascalp hair serum was found to be safe and effective in improving hair growth and strength in people with mild to moderate hair loss.

Some psychiatric drugs can cause severe hair loss, especially valproic acid, and it's more likely in women or those with thyroid issues or past hair loss.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

A 308 nm excimer laser successfully treated a boy with a rare skin condition after about a year of weekly sessions.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Melasma is now considered a skin aging disorder caused by sun exposure in people with a genetic tendency, which impacts treatment and prevention approaches.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

The symptoms described align more with Haberland syndrome, not Delleman-Oorthuys syndrome.

Collaborative care between physicians and pharmacists improved medication management for rheumatoid arthritis without raising costs.

TH07 is a topical combination of finasteride, latanoprost, and minoxidil, and shows promise.

The herbal mix (Biochanin A, Acetyl tetrapeptide-3, and Ginseng Extracts) and the 3% Minoxidil solution are equally effective in treating hair loss, but the herbal mix has fewer side effects.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Men's and women's pattern hair loss progress differently, with men showing more hair thinning and women having more widespread hair loss.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Certain herbal combinations in traditional Chinese medicine might be effective for treating hair loss, focusing on liver or stomach health.

Certain vitamins and their derivatives can help hair grow longer by activating specific growth signals.